Danaher

Sysmex accuses 13 Beckman Coulter instruments of infringing 11 claims in the patent, which covers a system analyzer and a computer program.

A court in San Diego has stated that part of the suit between Quidel and Beckman is void as a matter of law.

In a filing with the US Securities and Exchange Commission this week, Precipio said that it amended and restated an earlier securities purchase agreement with investors, The amendment enables it to issue up to $1.3 million of additional notes with applicable warrants, based on substantially the same terms and conditions as the notes and warrants granted in connection with the prior securities purchase agreement.

The classification indicates a reasonable probability that the use of, or exposure to, a recalled product will cause serious adverse health consequences or death.

Within diagnostics, Beckman Coulter saw core revenue growth in the low-single digits, while Cepheid was up in the double digits for the quarter.

The Canadian regulator gave Medical Device License approval to Beckman Coulter's DxH 900 Hematology Analyzer and its Early Sepsis Indicator.

The test detects and quantifies hepatitis C virus RNA and can be performed in approximately one hour. 

Genomic Vision announced this week that it has received a second payment from Quest Diagnostics related to the companies' collaboration for the development of new biomarkers to improve the genetic detection of spinal muscular atrophy. The company declined to disclose the amount of the payment.

Testing with Cepheid's molecular TB assay can shorten the amount of time suspected patients need to be isolated and save thousands of dollars per patient.